Guardian Pharmacy Services (GRDN) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
13 Oct, 2026Market position and model
ALF and memory-care pharmacy market estimated at ~$7B, with 1,000,000+ residents and 1,200+ independent pharmacies; aging population and rising acuity support demand.
Medication management is the top cited reason for entering an ALF; residents average ~85 years old, ~22-month median stay and 12–14 daily prescriptions.
2025 scale: ~205,000 residents, ~29 million prescriptions, ~90% adoption and 13% nationwide ALF market share.
Service model combines local pharmacy support with centralized capabilities, technology and clinical oversight to coordinate medication care and improve accuracy and adherence.
Growth strategy
Organic growth levers include adding facilities, increasing adoption and launching greenfield pharmacies; 21 greenfields were operating as of September 30, 2026.
Disciplined M&A targets operators serving national ALF demand or filling gaps in growth markets; typical targets have ~$10–$30 million revenue and 1,500–3,000 residents, with a target pool of ~100.
Greenfields and acquisitions are targeted to reach accretion by year 4, as margins approach the corporate average; levers include reimbursement, purchasing and national account sales.
Management projects high-single-digit organic growth at targeted operating margins for maturing locations.
Technology and resident outcomes
Guardian COMPASS supports purchasing, reimbursement optimization and drug-mix management; GuardianShield supports clinical interventions, regimen optimization and formulary alignment.
In FY2025, clinical interventions totaled ~100,000 and benefit optimization generated $56 million in savings to residents.
Proprietary technology, advanced robotics and eMAR integration are intended to improve dispensing accuracy and efficiency and support near-100% adherence and compliance.
Payor services include clinical interventions, formulary alignment, compliance packaging, medication-cycle synchronization and refill management to support adherence and network adequacy.
Latest events from Guardian Pharmacy Services
- Growth driven by local autonomy, strong balance sheet, and strategic expansion despite IRA headwinds.GRDN
2026 Jefferies Healthcare Services and Technology Conference - Q2 2026 net income rose to $22.1M on 2.2% revenue growth and an $8.5M settlement.GRDN
Q2 2026 - Tech-enabled growth and legislative advocacy position the company for continued market expansion.GRDN
Stephens 26th Annual Investment Conference | NASH2024 - Strong growth, stable margins, and expanding market share position the company for continued success.GRDN
Raymond James & Associates’ 46th Annual Institutional Investors Conference - Strong quarter, raised guidance, and poised for growth in the fragmented assisted living pharmacy market.GRDN
Bank of America Global Healthcare Conference 2026 - 13% ALF market share, $1.45B revenue, and tech-driven growth deliver strong outcomes.GRDN
Investor presentation - Q1 2026 revenue and net income rose, prompting higher full-year EBITDA guidance.GRDN
Q1 2026 - Expanding assisted living pharmacy services through tech, analytics, and strategic acquisitions.GRDN
Stephens Annual Investment Conference - Strong 2024 growth and expansion, with 2025 outlook positive despite IPO-related net loss.GRDN
Q4 2024